MedPath

Lisinopril and hydrochlorothiazide

Lisinopril and Hydrochlorothiazide Tablets Rx only

Approved
Approval ID

2937de2e-8c86-4248-917a-589b092e95ea

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 7, 2010

Manufacturers
FDA

State of Florida DOH Central Pharmacy

DUNS: 829348114

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LISINOPRIL AND HYDROCHLOROTHIAZIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53808-0452
Application NumberANDA078402
Product Classification
M
Marketing Category
C73584
G
Generic Name
LISINOPRIL AND HYDROCHLOROTHIAZIDE
Product Specifications
Route of AdministrationORAL
Effective DateJune 7, 2010
FDA Product Classification

INGREDIENTS (7)

TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
LISINOPRILActive
Quantity: 5 mg in 1 1
Code: E7199S1YWR
Classification: ACTIB
HYDROCHLOROTHIAZIDEActive
Quantity: 12.5 mg in 1 1
Code: 0J48LPH2TH
Classification: ACTIB
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lisinopril and hydrochlorothiazide - FDA Drug Approval Details